Trial · NCT07896616
Predicting the Need for Invasive Mechanical Ventilation Using Different Risk Scores
NCT07896616, Not yet recruiting, Ankara Ataturk Sanatorium Training and Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Predicting the Need for Invasive Mechanical Ventilation Using Different Risk Scores. Trials, record NCT07896616. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896616
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Predicting the Need for Invasive Mechanical Ventilation Using Different Risk Scores
- NCT number
- NCT07896616
- Status
- Not yet recruiting
- Enrollment
- 84 participants, estimated
- Lead sponsor
- Ankara Ataturk Sanatorium Training and Research Hospital
- Conditions
- High Flow Oxygen Therapy, Non Invasive Ventilation (NIV)
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Predictive Performance of the ROX Index for Invasive Mechanical Ventilation Requirement | Within 24 hours of ICU admission. | The predictive performance of the baseline ROX index for the need for invasive mechanical ventilation within 24 hours of ICU admission will be assessed using receiver operating characteristic (ROC) curve analysis. The outcome will be reported as the area under the ROC curve (AUC), ranging from 0 to 1. |
| Primary | Predictive Performance of the Modified ROX Index for Invasive Mechanical Ventilation Requirement | Within 24 hours of ICU admission. | The predictive performance of the baseline modified ROX index, calculated as (PaO2/FiO2)/respiratory rate, for the need for invasive mechanical ventilation within 24 hours of ICU admission will be assessed using ROC curve analysis. The outcome will be reported as the AUC, ranging from 0 to 1. |
| Primary | Predictive Performance of the HACOR Score for Invasive Mechanical Ventilation Requirement | Within 24 hours of ICU admission. | The predictive performance of the baseline HACOR score, incorporating heart rate, acidosis, consciousness, oxygenation, and respiratory rate, for the need for invasive mechanical ventilation within 24 hours of ICU admission will be assessed using ROC curve analysis. The outcome will be reported as the AUC, ranging from 0 to 1. |
| Secondary | Changes in ROX Score Over Time | Baseline, 2, 6, 12, and 24 hours. | Changes in ROX score from baseline to 2, 6, 12, and 24 hours will be evaluated in relation to invasive mechanical ventilation requirement. |
| Secondary | Changes in Modified ROX Score Over Time | Baseline, 2, 6, 12, and 24 hours. | Changes in modified ROX score from baseline to 2, 6, 12, and 24 hours will be evaluated in relation to invasive mechanical ventilation requirement. |
| Secondary | Changes in HACOR Score Over Time | Baseline, 2, 6, 12, and 24 hours. | Changes in HACOR score from baseline to 2, 6, 12, and 24 hours will be evaluated in relation to invasive mechanical ventilation requirement. |
| Secondary | Predictive Performance According to Respiratory Support Modality | Within 24 hours after intensive care admission. | The predictive performance of ROX, modified ROX, and HACOR indices will be compared among patients receiving HFNO, NIV, or sequential HFNO-NIV support. |
| Secondary | Predictive Performance According to Respiratory Failure Type | Within 24 hours after intensive care admission. | The predictive performance of ROX, modified ROX, and HACOR indices will be evaluated in patients with type I, type II, and combined type I-II acute respiratory failure. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07896616
GET https://conductscience.org/api/trials/v1/NCT07896616/registered